Differences in smoking expectancies in smokers with and without a history of major depression.
Adults with depression evidence higher rates of smoking and lower quit rates than adults without depression. Little is known about the relationship between depression and smoking beliefs which are associated with both smoking and smoking cessation behavior. The primary aim of this study was to examine whether adult smokers with and without a history of major depressive disorder (MDD) differ in their endorsement of smoking expectancies. The secondary aim of the study was to examine whether there were interactions of depression and gender on the endorsement of expectancies. Adult cigarette smokers participating in a clinical trial of Selegiline hydrochloride for smoking cessation were classified as having a history of depression (MDD+, n=26) or no history of depression (MDD-, n=75). History of depression and smoking expectancies were assessed prior to randomization into the clinical trial. There was a main effect of depression on 7 out of 10 of the assessed beliefs. MDD+ smokers, compared to MDD- smokers, more strongly endorsed beliefs that smoking reduces negative affect, boredom, and cravings; smoking increases stimulation and social facilitation; smoking helps to manage cravings and weight; and that the taste is enjoyable. The main effect of gender and the interactive effect of depression and gender were not significant. Incorporating expectancies into cognitive-behavioral treatments for smoking cessation may be useful for smokers with a history of depression.
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, USA. andrea.weinberger@yale.edu
Andrea H
AH
Weinberger
Tony P
TP
George
Sherry A
SA
McKee
D000293:Adolescent; D000328:Adult; D000368:Aged; D003865:Major Depressive Disorder / Q000453:epidemiology / Q000523:psychology*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D012642:Selegiline / Q000627:therapeutic use; D012737:Sex Factors; D012907:Smoking / Q000188:drug therapy / Q000453:epidemiology / Q000523:psychology*; D016540:Smoking Cessation / Q000379:methods; D011795:Surveys and Questionnaires; D055815:Young Adult
D008996:Monoamine Oxidase Inhibitors; D012642:Selegiline
Addict Behav. 1996 Jan-Feb;21(1):9-19
8729703
Nicotine Tob Res. 2008 Dec;10(12):1691-715
19023823
J Pers Soc Psychol. 1988 Jun;54(6):1063-70
3397865
J Consult Clin Psychol. 1996 Aug;64(4):791-8
8803370
J Am Coll Health. 2009 Mar-Apr;57(5):507-12
19254891
JAMA. 2000 Nov 22-29;284(20):2606-10
11086367
Psychol Addict Behav. 2000 Sep;14(3):219-30
10998948
Psychol Bull. 2003 Mar;129(2):270-304
12696841
Drug Alcohol Depend. 2008 Jan 11;93(1-2):176-9
17850991
J Subst Abuse. 2001;13(4):443-58
11775075
Clin Psychol Rev. 2005 Jun;25(4):487-510
15914266
Drug Alcohol Depend. 2010 Mar 1;107(2-3):188-95
19939587
Behav Res Ther. 1995 Jan;33(1):25-39
7872934
Addict Behav. 2004 Aug;29(6):1259-63
15236832
Br J Addict. 1988 Apr;83(4):393-402
3395719
Nicotine Tob Res. 2007 Jul;9(7):721-30
17577801
Psychol Rev. 2004 Jan;111(1):33-51
14756584
Br J Addict. 1991 Sep;86(9):1119-27
1932883
J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62
14399272
Arch Gen Psychiatry. 2004 Nov;61(11):1107-15
15520358
Arch Gen Psychiatry. 1998 Aug;55(8):683-90
9707377
Addict Behav. 2004 Jul;29(5):991-4
15219347
Addict Behav. 1997 May-Jun;22(3):377-86
9183507
Drug Alcohol Rev. 2006 Jan;25(1):97-107
16492582
Addict Behav. 2003 Sep;28(7):1257-70
12915167
J Stud Alcohol. 1999 Jul;60(4):566-76
10463814